ENDOXAN 1g powder for injection / infusion solution medication leaflet

L01AA01 cyclophosphamide • Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues

Cyclophosphamidum is a chemotherapy drug used to treat various types of cancer, including lymphomas, leukemias, and breast cancer. It belongs to the class of alkylating agents and works by destroying cancer cells and preventing them from dividing.

The medication is administered intravenously or orally, depending on the type and stage of cancer. It is often used in combination with other chemotherapy drugs to enhance treatment effectiveness.

Side effects may include nausea, vomiting, hair loss, fatigue, and an increased risk of infections. In rare cases, it may cause kidney or bladder toxicity. It is important to follow all medical recommendations to minimize risks.

Consult your doctor to discuss the benefits and risks of treatment with Cyclophosphamidum. Close monitoring is essential during treatment to manage potential side effects.

General data about ENDOXAN 1g

Substance: cyclophosphamide

Date of last drug list: 01-02-2025

Commercial code: W70832001

Concentration: 1g

Pharmaceutical form: powder for injection / infusion solution

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: BAXTER ONCOLOGY GMBH - GERMANIA

Holder: BAXTER HEALTHCARE S.R.L. - ROMANIA

Number: 9094/2016/01

Shelf life: 3 years

Concentrations available for cyclophosphamide

1000mg, 1000mg/2ml, 1g, 2000mg, 2000mg/4ml, 200mg, 200mg/ml, 500mg, 500mg/ml, 50mg

Other substances similar to cyclophosphamide